Laser showdown: which pulse setting saves sight best?

NCT ID NCT07266597

Not yet recruiting Disease control Sponsor: Sohag University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two different laser pulse settings (5% vs 15% duty cycle) in 50 adults with diabetic macular edema, a common cause of vision loss in diabetes. The goal is to see which setting is safer and more effective at reducing retinal swelling. Participants must have mild to moderate vision loss and no prior laser or injection treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: micropulse laser photocoagulation
What this could lead to: If this works, it could point toward a safer, more effective laser setting to control diabetic macular edema and preserve vision.
What could go wrong: This is a small, early-stage trial with only 50 participants. It compares two laser settings, not a new treatment, so the impact may be modest. Risks include potential vision loss or lack of improvement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETIC MACULAR EDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

diabetic macular edema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETIC MACULAR EDEMA

More trials for these conditions

Other studies related to the condition(s) this trial covers.